Zobrazeno 1 - 10
of 80
pro vyhledávání: '"S.V. Gritsaev"'
Autor:
Elena Romanovna Shilova, T.V. Glazanova, I.I. Kostroma, M.N. Zenina, O.E. Rozanova, Zh.V. Chubukina, R.R. Sabitova, N.A. Romanenko, V.A. Balashova, S.V. Gritsaev
Publikováno v:
Clinical oncohematology. 15:298-306
Aplastic anemia (AA) is a non-neoplastic hematological disease closely associated with bone marrow failure which is typical of paroxysmal nocturnal hemoglobinuria (PNH) and myelodysplastic syndrome (MDS). The PNH clones can be detected in more than a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N.Yu. Semenova, E. V. Vaneeva, V. A. Rosin, NV Minaeva, SV Samarina, D.A. Dyakonov, S.V. Gritsaev
Publikováno v:
Clinical oncohematology. 14:308-314
Aim. To study the value of PD-L1 protein expression in the combined model of diffuse large B-cell lymphoma (DLBCL) after administration of R-CHOP induction immunochemo-therapy. Materials & Methods. A retrospective analysis was based on the data of 85
Autor:
EV Karyagina, S.V. Gritsaev, AV Chechetkin, IM Zapreeva, II Kostroma, Elena I. Stepchenkova, N.Yu. Semenova, S.S. Bessmeltsev, AA Zhernyakova, Zh.Yu. Sidorova
Publikováno v:
Clinical oncohematology. 14:73-79
Background. Autologous hematopoietic stem cell transplantation (auto-HSCT) is an indispensable treatment stage in patients with newly diagnosed multiple myeloma (MM) who are, based on age and health status, eligible for high-dose chemotherapy with su
Autor:
O.Yu. Vinogradova, T.A. Ageeva, V.V. Baikov, A L Melikyan, Elena V. Morozova, S.V. Gritsaev, Tatiana Mitina, Boris V. Afanasyev, K. D. Kaplanov, Alla M. Kovrigina, Yu. V. Shatokhin, A.Yu. Zaritskey, I N Subortseva, E.S. Polushkina, Anna G. Turkina, T. I. Pospelova, Vasily Shuvaev, Elza Lomaia, Valeriy G. Savchenko, Roman G. Shmakov, A B Sudarikov, Sokolova Ma, Tatyana Ionova, Irina Martynkevich
Publikováno v:
Clinical oncohematology. 14:262-298
The development of National clinical guidelines on diagnosis and treatment of Ph-negative myeloproliferative neoplasms comes in response to the need to standardize the approach to diagnosis and treatment. The availability of clinical guidelines can f
Autor:
AV Chechetkin, Svetlana Pavlovna Svitina, S.I. Kapustin, II Kostroma, Zh.Yu. Sidorova, Zh V Chubukina, S.S. Bessmeltsev, AA Zhernyakova, S.V. Gritsaev
Publikováno v:
Clinical oncohematology. 14:340-346
Aim. To assess polymorphism value of interleukins (IL6, IL1B, IL10) and tumor necrosis factor α (TNF) genes in multiple myeloma (MM) patients who received autologous hematopoietic stem cell transplantation (auto-HSCT). Materials & Methods. The study
Autor:
II Kostroma, AV Chechetkin, Elena I. Stepchenkova, S.P. Svitina, AA Zhernyakova, Zh.Yu. Sidorova, N.Yu. Semenova, S.S. Bessmeltsev, S.V. Gritsaev, R.R. Sabitova
Publikováno v:
Clinical oncohematology. 14:333-339
Aim. To assess the rate of cases without antitumor response quality improvement after high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM). To assess the rate of allelic variants o
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anna S. Zhuk, Irina V. Zotova, Youri I. Pavlov, Anna Y. Aksenova, Ivan Ivanovich Kostroma, Artem G. Lada, S.V. Gritsaev, Elena I. Stepchenkova
Publikováno v:
Cancers
Cancers, Vol 13, Iss 5949, p 5949 (2021)
Cancers, Vol 13, Iss 5949, p 5949 (2021)
Simple Summary Multiple myeloma is an incurable blood cancer caused by the malignant transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the origin of cancerous cells and the evolution of myeloma disease are not underst
Publikováno v:
Problems in oncology. 65:504-509
The review discusseds some problems of autotransplant harvesting in patients with multiple myeloma (MM). The main mobilization regimens and their modifications ensured receipt of suboptimal of CD34+ cells number are described. The expansion of mobili